Description
The Creatinine (Crea) Gen.2 (Sarcosine Oxidase Method) is a groundbreaking solution for antidrug interference that efficiently eliminates the interferences of calcium dobesilate and etamsylate in the sample. Calcium dobesilate and etamsylate result in lower results tested by enzymatic creatinine and affect clinical judgments.
Specification
Drug Name Effectiveness Clinical Application Interferences
Calcium Dobesilate Vascular Protective Agent Diabetic Microangiopathy, Diabetic Eye Diseases, DN, DPN, Elderly Coronary Heart Disease Angina. Enzymatic creatinine reagents will be negatively interfered. The deviation of results will be up to -60%, with the increasing of the drug concentration, even worse for those patients with poor renal function.
Etamsylate Hemostatic Drug Bleeding prevention before and after surgery, bleeding caused by factors of blood and blood vessel, such as thrombocytopenic purpura, cerebral hemorrhage, gastrointestinal, urinary tract, fundus, gum, and nose bleeding, etc. Enzymatic creatinine reagents will be negatively interfered. The deviation of results will be up to -70%, with the increasing of the drug concentration.